March 2026
M	T	W	T	F	S	S
	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Nathan Connell on the 1st von Willebrand Factor/Factor VIII Relevance Academy

Nathan Connell/LinkedIn

Dec 9, 2025, 04:36

Nathan Connell on the 1st von Willebrand Factor/Factor VIII Relevance Academy

Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared on LinkedIn:

”We recently held the first von Willebrand Factor/Factor VIII Relevance Academy in Orlando, Florida.

It was a wonderful day of learning and discussion about so many topics of importance to the hemostasis community.

From basic science to clinical and epidemiologic applications, I was excited to see so much focus on improving the quality of life for those with inherited bleeding disorders.

I was asked to present on the role of VWF concentrate prophylaxis in people with von Willebrand disease.

We have more data now than we did when the international VWD guidelines were published in 2021.

Still, we continue to have so many questions about who would benefit the most and how to optimize our prophylaxis strategies.

Thank you to the always outstanding Octapharma team, including Stefano Carta, Belyanskaya Larisa, Claudio Sandoval, and many others, as well as Academy chair Robert Sidonio, and all the faculty and participants who contributed to the discussion.”

Nathan Connell on the 1st von Willebrand Factor/Factor VIII Relevance Academy